Sigma Research
TwitterFacebookVimeo

EMIS-2017: Planned Scientific Articles

As of July 2019, we have provided EMIS-2017 data for 38 National Reports. They will be provided as PDFs elsewhere on this website.

International EMIS data for scientific articles can now be requested by members of the EMIS network. Merged 2010 and 2017 data is now available. Data request form are available via e-mail. Please contact coordinator@emis-project.eu.

The following publication requests have been reviewed by the EMIS editorial board.

Title: Level and description of MSM who are eligible but not using PrEP: French results from a nationwide internet survey (EMIS 2017)
Lead author: Margot Annequin
Data set: EMIS-FR (2017)
Research question and objectives: In France, PrEP was implemented in January 2016, has been fully reimbursed by the French national health insurance system since March 2017 and is recommended for men who have sex with men (MSM) with high risk of HIV infection. MSM represent 42% of new HIV diagnoses in France, thus it has been estimated that 50 000 MSM would be in PrEP need. However according to French social security data, 10 000 people have been reimbursed for PrEP as of the first semester of 2018. In order to increase PrEP coverage, we need to better characterise individuals who may benefit from PrEP but are not using it. Objectives of this study are to assess the percentage and describe MSM eligible to PrEP but non-users and to assess factors associated with being an eligible non PreP-user (ENPU).
Analytic plan: This analysis will be restricted to participants living in France, who declared being HIV-negative or never tested for HIV. Adapted to French guidelines, we will define PrEP eligibility as meeting at least one of three criteria: having condomless intercourse with ≥ 2 different partners in the last 12 months, having a history of post-exposure prophylaxis use or engaging in chemsex in the last 12 months We will assess the percentage of PrEP users and Eligible non PrEP-user (ENPU) amongst all French EMIS respondents, excluding those declaring HIV positive status. Socio-demographic characteristics, sexual behaviours and HIV knowledge will be compare between PrEP users and ENPU and factors associated with ENPU will assess using logistic regression models, comparing ENPU to PrEP users. This analysis will be restricted to participants living in France, who declared being HIV-negative or never tested for HIV. Adapted to French guidelines, we will define PrEP eligibility as meeting at least one of three criteria: having condomless intercourse with ≥ 2 different partners in the last 12 months, having a history of post-exposure prophylaxis use or engaging in chemsex in the last 12 months. We will assess the percentage of PrEP users and Eligible non PreP-user (ENPU) amongst all French EMIS respondents, excluding those declaring HIV positive status. Socio-demographic characteristics, sexual behaviours and HIV knowledge will be compare between PrEP users and ENPU and factors associated with ENPU will assess using logistic regression models, comparing ENPU to PrEP users. This analysis will be restricted to participants living in France, who declared being HIV-negative or never tested for HIV. Adapted to French guidelines, we will define PrEP eligibility as meeting at least one of three criteria: having condomless intercourse with ≥ 2 different partners in the last 12 months, having a history of post-exposure prophylaxis use or engaging in chemsex in the last 12 months. We will assess the percentage of PrEP users and Eligible non PreP-user (ENPU) amongst all French EMIS respondents, excluding those declaring HIV positive status. Socio-demographic characteristics, sexual behaviours and HIV knowledge will be compare between PrEP users and ENPU and factors associated with ENPU will assess using logistic regression models, comparing ENPU to PrEP users.
Abstract presented at: AIDS impact (oral presentation)
Target journal: AIDS
Date of approval: 28.3.2019 

 

Title: An update on the comparison of the performance of STI screening services for gay and bisexual men across 40 European cities: Results from the 2017 European MSM Internet Survey (EMIS-2017)
Lead authorAxel J. Schmidt (Jason Doran)
Data set: EMIS-2017
Research question and objectives: Rectal manifestations of sexually transmitted infections (STIs) compromise the health of gay and bisexual men. In 2010 across 40 cities among men screened for STIs, anal swabbing was highest in London and Amsterdam with rates of more than 72%, but low across most other European cities. We apply the same methodology for comparing diagnostic procedures for MSM across the same European cities for 2017, in order to see if the gap between London/Amsterdam and other European cities has narrowed.
Analytic plan: See https://sti.bmj.com/content/89/7/575.info. As sexual healthcare for MSM in most countries is organised locally, we choose cities for comparison and focus on a sub-sample of 38,439 men living the same 40 European cities. We use the same multivariable regression model as in 2012 to compare the odds of having received anal swabbing in the 12 months, controlling for age, HIV diagnosis, and the number of sexual partners. We plan to have an online appendix where all 105 EMIS-2017 cities are included, sorted by country.
Abstract presented at: STI and HIV Vancouver (oral presentation)
Target journal: STI
Date of approval: 16.5.2019